MURINE SUPPLEMENTAL TEARS 10 MG / 100 ML
BENZALKONIUM CHLORIDE : 10 MG / 100 ML DISODIUM EDETATE : 50 MG / 100 ML · DIN 00495522 · ABBOTT LABORATORIES, LIMITED
Health Canada status: CANCELLED POST MARKET
What is MURINE SUPPLEMENTAL TEARS?
MURINE SUPPLEMENTAL TEARS 10 MG / 100 ML contains BENZALKONIUM CHLORIDE : 10 MG / 100 ML DISODIUM EDETATE : 50 MG / 100 ML. It is listed in the Health Canada Drug Product Database under DIN 00495522, held by ABBOTT LABORATORIES, LIMITED, supplied as LIQUID for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 10-Oct-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00495522 |
|---|---|
| Brand name | MURINE SUPPLEMENTAL TEARS |
| Generic / active ingredient | BENZALKONIUM CHLORIDE : 10 MG / 100 ML DISODIUM EDETATE : 50 MG / 100 ML |
| Manufacturer | ABBOTT LABORATORIES, LIMITED |
| Strength | 10 MG / 100 ML |
| Dosage form | LIQUID |
| Route of administration | OPHTHALMIC |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS. |
| AHFS class | 52:92.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Oct-2003 |
| Original market date | 1980-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS.. 26 of 94 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALCON TEARS 0.5% | 0.5 % | SOLUTION | ALCON CANADA INC | MARKETED | DIN 00000809 |
| ALCON TEARS 1% | 1 % | SOLUTION | ALCON CANADA INC | MARKETED | DIN 00000817 |
| AMO ENDOSOL SOLUTION | 0.17 % | SOLUTION | AMO CANADA COMPANY | MARKETED | DIN 02007967 |
| ARTIFICIAL TEARS | 0.2 % | SOLUTION | JUNO OTC INC | MARKETED | DIN 02354535 |
| DRY EYE TEARS | 0.2 % | SOLUTION | JUNO OTC INC | MARKETED | DIN 02389886 |
| LUBRICANT EYE DROPS/ ARTIFICIAL TEARS | 0.3 % | DROPS | BAUSCH & LOMB INC | MARKETED | DIN 02321696 |
| MIEBO | 100 % | SOLUTION | BAUSCH & LOMB INC | MARKETED | DIN 02551403 |
| MURINE | 6 MG | SOLUTION | PRESTIGE BRANDS INC | MARKETED | DIN 02247538 |
| PRESERVATIVE-FREE THERA TEARS LUBRICANT EYE DROPS | 0.25 % | DROPS | MEDTECH PRODUCTS INC | MARKETED | DIN 02242082 |
| REFRESH | 1.4 % | DROPS | ABBVIE CORPORATION | MARKETED | DIN 02138670 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.